Canada's rare disease landscape presents a unique opportunity to revolutionize healthcare through a learning health ecosystem, but it requires a strategic approach to data infrastructure and governance. The country has made significant strides in developing innovative programs and infrastructure, yet these efforts often face challenges due to short-term funding cycles and limited budgets. This article explores the importance of data sharing, discovery research, and a federated approach to building a sustainable and integrated system for managing rare diseases in Canada.
The Power of Data Sharing
Genomic DNA sequencing has revolutionized the diagnosis of rare diseases, but it's the data sharing that truly unlocks its potential. By comparing an individual's DNA sequence to large-scale datasets, researchers can determine the causative nature of genetic variants. This process relies on accessing or exchanging information from various sources, a practice known as data sharing. The All for One Data Sharing Agreement in Canada has facilitated responsible data sharing between diagnostic laboratories, and initiatives like the Canadian Open Genetics Repository and the Silent Genome's Indigenous Background Variant Library further enhance genomic interpretation.
However, data sharing is not just about access; it's about trust and representation. The Indigenous Background Variant Library, for instance, was created in partnership with Indigenous communities to ensure cultural safety and Indigenous data sovereignty. This highlights the importance of governance models that respect community partnership and prioritize ethical data handling.
The Role of Discovery Research
Accurate diagnosis of rare diseases also hinges on ongoing discovery research. Many patients harbor variants in genes not yet definitively linked to disease, requiring research initiatives to uncover associations between uncharacterized genes and unsolved RDs. Care4Rare, a Canadian research program, exemplifies this by analyzing genomic data and linking it to global databases, fostering crucial evidence for disease-gene relationships.
The Pan-Canadian Genome Library further strengthens Canada's genomic research capabilities by providing a centralized resource for storing and sharing Canadian genomic data. This centralized approach improves data accessibility and supports future research, underscoring the need for governance and infrastructure that facilitates interconnected and sustainable data sharing across healthcare and research.
Building a Sustainable System
Canada's distributed health system presents a unique challenge. While the country has impressive individual efforts, they are not enough to create a sustainable learning health system. A federated approach, where data remains within trusted institutions while becoming discoverable and comparable through shared standards, governance, and infrastructure, offers a solution.
This approach aligns with the Pan-Canadian Health Data Strategy's call for stronger health data foundations, including federated governance, interoperability, supportive policy, and public engagement. To make responsible data sharing routine, Canada needs federal leadership, recognizing data sharing as core diagnostic infrastructure, establishing national standards for RD testing and data, and involving patients, families, and communities in governance.
The Way Forward
Canada has the potential to transform its rare disease management system, but it requires a comprehensive strategy. By treating data sharing as core health infrastructure, providing sustained investment, policy alignment, and coordination across jurisdictions and sectors, the country can build a robust learning health ecosystem. This approach will not only improve diagnosis and research but also enhance patient outcomes and contribute to a more equitable and efficient healthcare system.
In conclusion, Canada's rare disease landscape presents a unique opportunity to revolutionize healthcare through a learning health ecosystem. By embracing data sharing, discovery research, and a federated approach, the country can create a sustainable and integrated system that benefits patients, researchers, and the healthcare system as a whole.
